Skip to main content
SpringerLink
Log in

Evidence Based Approach to the Management of Persistent Pulmonary Hypertension of the Newborn (PPHN)

  • Chapter
  • First Online:
Emerging Topics and Controversies in Neonatology

  • 877 Accesses

Abstract

Persistent pulmonary hypertension of the newborn (PPHN) is characterised by severe hypoxemia requiring timely recognition and treatment to improve mortality and morbidity. The clinical scenario may often mimic cyanotic heart disease, posing diagnostic challenges to neonatologists and paediatricians. This chapter summarises key concepts of PPHN to enable clinicians to navigate their way to accurate diagnosis and initiate interventions based on available evidence where possible. Newer therapies and on-going research are also briefly summarised.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Perez KM, Laughon M. Sildenafil in term and premature infants: a systematic review. Clin Ther. 2015;37(11):2598–2607.e1.

    Article  CAS  PubMed  Google Scholar 

  2. Kelly LE, Ohlsson A, Shah PS. Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev. 2017;8:CD005494.

    PubMed  Google Scholar 

  3. Nair J, Lakshminrusimha S. Update on PPHN: mechanisms and treatment. Semin Perinatol. 2014;38(2):78–91.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Wild LM, Nickerson PA, Morin FC. Ligating the ductus arteriosus before birth remodels the pulmonary vasculature of the lamb. Pediatr Res. 1989;25(3):251–7.

    Article  CAS  PubMed  Google Scholar 

  5. Szafranski P, Gambin T, Dharmadhikari AV, Akdemir KC, Jhangiani SN, Schuette J, et al. Pathogenetics of alveolar capillary dysplasia with misalignment of pulmonary veins. Hum Genet. 2016;135(5):569–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Hamvas A, Cole FS, Nogee LM. Genetic disorders of surfactant proteins. Neonatology. 2007;91(4):311–7.

    Article  CAS  PubMed  Google Scholar 

  7. Shulenin S, Nogee LM, Annilo T, Wert SE, Whitsett JA, Dean M. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med. 2004;350(13):1296–303.

    Article  CAS  PubMed  Google Scholar 

  8. Byers HM, Dagle JM, Klein JM, Ryckman KK, McDonald EL, Murray JC, et al. Variations in CRHR1 are associated with persistent pulmonary hypertension of the newborn. Pediatr Res. 2012;71(2):162–7.

    Article  CAS  PubMed  Google Scholar 

  9. Van Marter LJ, Hernandez-Diaz S, Werler MM, Louik C, Mitchell AA. Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn. Pediatrics. 2013;131(1):79–87.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Winovitch KC, Padilla L, Ghamsary M, Lagrew DC, Wing DA. Persistent pulmonary hypertension of the newborn following elective cesarean delivery at term. J Matern Neonatal Med. 2011;24(11):1398–402.

    Article  Google Scholar 

  11. Thoresen M. Hypothermia after perinatal asphyxia: Selection for treatment and cooling protocol. J Pediatr. 2011;158(Suppl 2):e45–9.

    Article  PubMed  Google Scholar 

  12. Eicher DJ, Wagner CL, Katikaneni LP, Hulsey TC, Bass WT, Kaufman DA, et al. Moderate hypothermia in neonatal encephalopathy: efficacy outcomes. Pediatr Neurol. 2005;32:11–7.

    Article  PubMed  Google Scholar 

  13. Ewer AK, Middleton LJ, Furmston AT, Bhoyar A, Daniels JP, Thangaratinam S, et al. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. Lancet. 2011;378(9793):785–94.

    Article  PubMed  Google Scholar 

  14. Lakshminrusimha S, Wynn RJ, Youssfi M, Pabalan MJ, Bommaraju M, Kirmani K, et al. Use of CT angiography in the diagnosis of total anomalous venous return. J Perinatol. 2009;29(6):458–61.

    Article  CAS  PubMed  Google Scholar 

  15. Berenz A, Vergales JE, Swanson JR, Sinkin RA. Evidence of early pulmonary hypertension is associated with increased mortality in very low birth weight infants. Am J Perinatol. 2017;34(8):801–7.

    Article  PubMed  Google Scholar 

  16. Puthiyachirakkal M, Mhanna MJ. Pathophysiology, management, and outcome of persistent pulmonary hypertension of the newborn: a clinical review. Front Pediatr. 2013;1:23.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Skinner JR, Hunter S, Hey EN. Haemodynamic features at presentation in persistent pulmonary hypertension of the newborn and outcome. Arch Dis Child Fetal Neonatal Ed. 2008;74(1):F26–32.

    Article  Google Scholar 

  18. Fraisse A, Geva T, Gaudart J, Wessel DL. Doppler echocardiographic predictors of outcome in newborns with persistent pulmonary hypertension. Cardiol Young. 2004;14(3):277–83.

    Article  PubMed  Google Scholar 

  19. Aggarwal S, Natarajan G. Echocardiographic correlates of persistent pulmonary hypertension of the newborn. Early Hum Dev. 2015;91(4):285–9.

    Article  PubMed  Google Scholar 

  20. Bendapudi P, Rao GG, Greenough A. Diagnosis and management of persistent pulmonary hypertension of the newborn. Paediatr Respir Rev. 2015;16(3):157–61.

    PubMed  Google Scholar 

  21. King ME, Braun H, Goldblatt A, Liberthson R, Weyman AE. Interventricular septal configuration as a predictor of right ventricular systolic hypertension in children: a cross-sectional echocardiographic study. Circulation. 1983;68(1):68–75.

    Article  CAS  PubMed  Google Scholar 

  22. Dhillon R. The management of neonatal pulmonary hypertension. Arch Dis Child Fetal Neonatal Ed. 2012;97(3):F223–8.

    Article  PubMed  Google Scholar 

  23. Reynolds EW. Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn: in reply. Pediatrics. 2005;114(5):1297–304.

    Article  Google Scholar 

  24. Vijlbrief DC, Benders MJ, Kemperman H, van Bel F, de Vries WB. B-type natriuretic peptide and rebound during treatment for persistent pulmonary hypertension. J Pediatr. 2012;160(1):111–5.e1.

    Article  CAS  PubMed  Google Scholar 

  25. Cheung PY, Tyebkhan JM, Peliowski A, Ainsworth W, Robertson CMT. Prolonged use of pancuronium bromide and sensorineural hearing loss in childhood survivors of congenital diaphragmatic hernia. J Pediatr. 1999;135(2 Pt 1):233–9.

    Article  CAS  PubMed  Google Scholar 

  26. Walsh-Sukys MC, Tyson JE, Wright LL, Bauer CR, Korones SB, Stevenson DK, et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics. 2000;105(1 Pt 1):14–20.

    Article  CAS  PubMed  Google Scholar 

  27. Agrawal. Persistent pulmonary hypertension of the newborn: recent advances in the management. Int J Clin Pediatr. 2013;89(3):226–42.

    Google Scholar 

  28. Tourneux P, Rakza T, Bouissou A, Krim G, Storme L. Pulmonary circulatory effects of norepinephrine in newborn infants with persistent pulmonary hypertension. J Pediatr. 2008;153(3):345–9.

    Article  CAS  PubMed  Google Scholar 

  29. Ostrea EM, Villanueva-Uy ET, Natarajan G, Uy HG. Persistent pulmonary hypertension of the newborn: pathogenesis, etiology, and management. Pediatr Drugs. 2006;8(3):179–88.

    Article  Google Scholar 

  30. Lotze A, Mitchell BR, Bulas DI, Zola EM, Shalwitz RA, Gunkel JH, et al. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. J Pediatr. 1998;132(1):40–7.

    Article  CAS  PubMed  Google Scholar 

  31. Gadzinowski J, Kowalska K, Vidyasagar D. Treatment of MAS with PPHN using combined therapy: SLL, bolus surfactant and iNO. J Perinatol. 2008;28(Suppl 3):S56–66.

    Article  CAS  PubMed  Google Scholar 

  32. Bifano EM, Pfannenstiel A. Duration of hyperventilation and outcome in infants with persistent pulmonary hypertension. Pediatrics. 1988;81(5):657–61.

    CAS  PubMed  Google Scholar 

  33. Hendricks-Munoz KD, Walton J. Hearing loss in infants with persistent fetal circulation. Pediatrics. 1988;81(5):650–6.

    CAS  PubMed  Google Scholar 

  34. Dworetz A, Moya F, Sabo B, et al. Survival of infants with persistent pulmonary hypertension without extracorporeal membrane oxygenation. Pediatrics. 1989;84(1):1–6.

    CAS  PubMed  Google Scholar 

  35. Wung JT, James LS, Kilchevsky E, James E. Management of infants with severe respiratory failure and persistence of the fetal circulation, without hyperventilation. Pediatrics. 1985;76(4):488–94.

    CAS  PubMed  Google Scholar 

  36. Rudolph AM, Yuan S. Response of the pulmonary vasculature to hypoxia and H+ ion concentration changes. J Clin Invest. 1966;45(3):399–411.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Konduri GG, Kim UO. Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatr Clin North Am. 2009;56(3):579–600.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Kinsella JP, Abman SH. Clinical approach to inhaled nitric oxide therapy in the newborn with hypoxemia. J Pediatr. 2000;136(6):717–26.

    CAS  PubMed  Google Scholar 

  39. Gao Y, Ray J. Regulation of the pulmonary circulation in the fetus and newborn. Circulation. 2010;90(4):1291–335.

    CAS  Google Scholar 

  40. Barrington K, Finer N. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev. 2007;(12):CD000509.

    Google Scholar 

  41. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med. 1997;336(9):597–604.

    Article  Google Scholar 

  42. Konduri GG, Solimano A, Sokol GM, Singer J, Ehrenkranz RA, Singhal N, et al. A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure. Pediatrics. 2004;113(3 Pt 1):559–64.

    Article  PubMed  Google Scholar 

  43. Shivananda S, Ahliwahlia L, Kluckow M, Luc J, Jankov R, McNamara P. Variation in the management of persistent pulmonary hypertension of the newborn: a survey of physicians in Canada, Australia, and New Zealand. Am J Perinatol. 2012;29(7):519–26.

    PubMed  Google Scholar 

  44. Soll RF. Inhaled nitric oxide in the neonate. J Perinatol. 2009;29(Suppl 2):S63–7.

    Article  CAS  PubMed  Google Scholar 

  45. Kinsella JP. Clinical trials of inhaled nitric oxide therapy in the newborn. Pediatr Rev. 2018;20(11):e110–3.

    Article  Google Scholar 

  46. Peliowski A, Jefferies AL, Lacaze-Masmonteil T, Sorokan ST, Stanwick R, Whyte HEA, et al. Inhaled nitric oxide use in newborns. Paediatr Child Health. 2012;17(2):95–7.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Davidson D, Barefield ES, Kattwinkel J, Dudell G, Damask M, Straube R, et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group. Pediatrics. 1998;101(3 Pt 1):325–34.

    Article  CAS  PubMed  Google Scholar 

  48. Davidson D, Barefield ES, Kattwinkel J, Dudell G, Damask M, Straube R, et al. Safety of withdrawing inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn. Pediatrics. 1999;104(2 Pt 1):231–6.

    Article  CAS  PubMed  Google Scholar 

  49. Steinhorn RH, Kinsella JP, Pierce C, Butrous G, Dilleen M, Oakes M, et al. Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension. J Pediatr. 2009;155(6):841–847.e1.

    Article  CAS  PubMed  Google Scholar 

  50. Lakshminrusimha S, Mathew B, Leach CL. Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide. Semin Perinatol. 2016;40(3):160–73.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Lakshminrusimha S, Steinhorn RH. Inodilators in nitric oxide resistant persistent pulmonary hypertension of the newborn. Pediatr Crit Care Med. 2013;14(1):107–9.

    Article  PubMed  Google Scholar 

  52. Bassler D, Kreutzer K, McNamara P, Kirpalani H. Milrinone for persistent pulmonary hypertension of the newborn. Cochrane Database Syst Rev. 2010;(11):CD007802.

    Google Scholar 

  53. McNamara PJ, Laique F, Muang-In S, Whyte HE. Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn. J Crit Care. 2006;21(2):217–22.

    Article  CAS  PubMed  Google Scholar 

  54. Ahmad KA, Banales J, Henderson CL, Ramos SE, Brandt KM, Powers GC. Intravenous epoprostenol improves oxygenation index in patients with persistent pulmonary hypertension of the newborn refractory to nitric oxide. J Perinatol. 2018;38(9):1212–9.

    Article  CAS  PubMed  Google Scholar 

  55. Golzand E, Bar-Oz B, Arad I. Intravenous prostacyclin in the treatment of persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide. Isr Med Assoc J. 2005;7(6):408–9.

    PubMed  Google Scholar 

  56. Gabbay E, Fraser J, McNeil K. Review of bosentan in the management of pulmonary arterial hypertension. Vasc Health Risk Manag. 2007;3(6):887–900.

    CAS  PubMed  PubMed Central  Google Scholar 

  57. Rao S, Bartle D, Patole S. Current and future therapeutic options for persistent pulmonary hypertension in the newborn. Expert Rev Cardiovasc Ther. 2010;8(6):845–62.

    Article  CAS  PubMed  Google Scholar 

  58. Nakwan N, Choksuchat D, Saksawad R, Thammachote P, Nakwan N. Successful treatment of persistent pulmonary hypertension of the newborn with bosentan. Acta Paediatr Int J Paediatr. 2009;98(10):1683–5.

    Article  CAS  Google Scholar 

  59. Mohamed WA, Ismail M. A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn. J Perinatol. 2012;32(8):608–13.

    Article  CAS  PubMed  Google Scholar 

  60. Ho JJ, Rasa G. Magnesium sulfate for persistent pulmonary hypertension of the newborn. Cochrane Database Syst Rev. 2007;(3):CD005588.

    Google Scholar 

  61. Boo NY, Rohana J, Yong SC, Bilkis AZ, Yong-Junina F. Inhaled nitric oxide and intravenous magnesium sulphate for the treatment of persistent pulmonary hypertension of the newborn. Singapore Med J. 2010;51(2):144–50.

    CAS  PubMed  Google Scholar 

  62. Mohamed A, Nasef N, Shah V, McNamara PJ. Vasopressin as a rescue therapy for refractory pulmonary hypertension in neonates: case series. Pediatr Crit Care Med. 2014;15(2):148–54.

    Article  PubMed  Google Scholar 

  63. Bennett CC, Johnson A, Field DJ, Elbourne D. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years. Lancet. 2001;357(9262):1094–6.

    Article  CAS  PubMed  Google Scholar 

  64. Mugford M, Elbourne D, Field D. Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants. Cochrane Database Syst Rev. 2008;(3):CD001340.

    Google Scholar 

  65. Lazar DA, Cass DL, Olutoye OO, Welty SE, Fernandes CJ, Rycus PT, et al. The use of ECMO for persistent pulmonary hypertension of the newborn: a decade of experience. J Surg Res. 2012;177(2):263–7.

    Article  CAS  PubMed  Google Scholar 

  66. Rosenberg AA, Lee NR, Vaver KN, Werner D, Fashaw L, Hale K, Waas N, et al. School-age outcomes of newborns treated for persistent pulmonary hypertension. J Perinatol. 2010;30(2):127–34.

    Article  CAS  PubMed  Google Scholar 

  67. Finer N. Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of The Neonatal Inhaled Nitric Oxide Study Group (NINOS). J Pediatr. 2000;136(5):611–7.

    Article  CAS  Google Scholar 

  68. Eriksen V, Nielsen LH, Klokker M, Greisen G. Follow-up of 5- to 11-year-old children treated for persistent pulmonary hypertension of the newborn. Acta Paediatr. 2009;98(2):304–9.

    Article  PubMed  Google Scholar 

  69. Lakshminrusimha S, Russell JA, Wedgwood S, Gugino SF, Kazzaz JA, Davis JM, et al. Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension. Am J Respir Crit Care Med. 2006;174(12):1370–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Wedgwood S, Lakshminrusimha S, Farrow KN, Czech L, Gugino SF, Soares F, et al. Apocynin improves oxygenation and increases eNOS in persistent pulmonary hypertension of the newborn. Am J Physiol Cell Mol Physiol. 2011;302(6):L616–26.

    Article  CAS  Google Scholar 

  71. Chandrasekar I, Eis A, Konduri GG. Betamethasone attenuates oxidant stress in endothelial cells from fetal lambs with persistent pulmonary hypertension. Pediatr Res. 2008;63(1):67–72.

    Article  CAS  PubMed  Google Scholar 

  72. Deruelle P, Balasubramaniam V, Kunig AM, Seedorf GJ, Markham NE, Abman SH. BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats. Biol Neonate. 2006;90(2):135–44.

    Article  CAS  PubMed  Google Scholar 

  73. Fike CD, Dikalova A, Kaplowitz MR, Cunningham G, Summar M, Aschner JL. Rescue treatment with L-citrulline inhibits hypoxia-induced pulmonary hypertension in newborn pigs. Am J Respir Cell Mol Biol. 2015;53(2):255–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Parker TA, Roe G, Grover TR, Abman SH. Rho kinase activation maintains high pulmonary vascular resistance in the ovine fetal lung. Am J Physiol Cell Mol Physiol. 2006;291(5):L976–82.

    Article  CAS  Google Scholar 

  75. Wolf D, Tseng N, Seedorf G, Roe G, Abman SH, Gien J. Endothelin-1 decreases endothelial PPARγ signaling and impairs angiogenesis after chronic intrauterine pulmonary hypertension. Am J Physiol Cell Mol Physiol. 2013;306(4):L361–71.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Hospitals of Leicester NHS Trust, Leicester, UK

    Venkatesh Kairamkonda & Sumit Mittal

Authors
  1. Venkatesh Kairamkonda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sumit Mittal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sumit Mittal .

Editor information

Editors and Affiliations

  1. Department of Health Sciences, George Davies Centre for Medicine, University of Leicester, Leicester, UK

    Elaine M. Boyle

  2. Department of Health Sciences, George Davies Centre for Medicine, University of Leicester, Leicester, UK

    Jonathan Cusack

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kairamkonda, V., Mittal, S. (2020). Evidence Based Approach to the Management of Persistent Pulmonary Hypertension of the Newborn (PPHN). In: Boyle, E., Cusack, J. (eds) Emerging Topics and Controversies in Neonatology. Springer, Cham. https://doi.org/10.1007/978-3-030-28829-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-28829-7_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-28828-0

  • Online ISBN: 978-3-030-28829-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation